Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Odyna P 750mcg/75mg Capsule may be taken with or without food, but it is better to take it at a fixed time.
Odyna P 750mcg/75mg Capsule is a combination of two medicines: Methylcobalamin and Pregabalin. Methylcobalamin is a form of vitamin B which helps in the production of myelin, a substance that protects nerve fibers and rejuvenates damaged nerve cells. Pregabalin is an alpha 2 delta ligand which decreases pain by modulating calcium channel activity of the nerve cells. Together, they relieve neuropathic pain (pain from damaged nerves).
Odyna P 750mcg/75mg Capsule may cause excessive drowsiness and calmness with alcohol.
WEIGH RISKS VS BENEFITS
Odyna P 750mcg/75mg Capsule may be unsafe to use during pregnancy. Animal studies have shown adverse effects on the foetus, however, there are limited human studies. The benefits from use in pregnant women may be acceptable despite the risk. Please consult your doctor.
Odyna P 750mcg/75mg Capsule is probably unsafe to use during lactation.
Limited human data suggest that the drug could represent a significant risk to the baby.
Odyna P 750mcg/75mg Capsule may make you feel dizzy, sleepy, tired, or decrease alertness. If this happens, do not drive.
Odyna P 750mcg/75mg Capsule should be used with caution in patients with kidney disease. Dose adjustment of Odyna P 750mcg/75mg Capsule may be needed. Please consult your doctor.
Odyna P 750mcg/75mg Capsule is probably safe to use in patients with liver disease. Limited data available suggests that dose adjustment of Odyna P 750mcg/75mg Capsule may not be needed in these patients. Please consult your doctor.
“The following are the results of on-going survey on 1mg.com for Odyna P 750mcg/75mg Capsule. These results only indicate the perceptions of the website users. Please base your medical decisions only on the advice of a doctor or a registered medical professional.”
Information last updated by Dr. Varun Gupta, MD Pharmacology on 8th Mar 2017.